Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 21.55
(-0.23%)
CNY 21.55
(-0.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.1 Billion CNY | -34.51% |
| 2022 | -824.42 Million CNY | -28.38% |
| 2021 | -642.18 Million CNY | -11.9% |
| 2020 | -573.87 Million CNY | 23.56% |
| 2019 | -750.77 Million CNY | -63.2% |
| 2018 | -460.04 Million CNY | -147.58% |
| 2017 | -185.81 Million CNY | 21.09% |
| 2016 | -235.47 Million CNY | 13.37% |
| 2015 | -271.8 Million CNY | 1.33% |
| 2014 | -275.47 Million CNY | -166.58% |
| 2013 | -103.33 Million CNY | -61.32% |
| 2012 | -64.05 Million CNY | -100.17% |
| 2011 | -32 Million CNY | -83.62% |
| 2010 | -17.42 Million CNY | 59.93% |
| 2009 | -43.48 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -1.04 Billion CNY | 9.82% |
| 2024 Q2 | -1.15 Billion CNY | -3.11% |
| 2024 Q1 | -1.11 Billion CNY | -0.94% |
| 2023 FY | -1.1 Billion CNY | -34.51% |
| 2023 Q3 | -1.03 Billion CNY | 9.44% |
| 2023 Q1 | -880.67 Million CNY | -6.82% |
| 2023 Q4 | -1.1 Billion CNY | -7.64% |
| 2023 Q2 | -1.13 Billion CNY | -29.17% |
| 2022 Q1 | -716.02 Million CNY | -11.5% |
| 2022 FY | -824.42 Million CNY | -28.38% |
| 2022 Q4 | -824.42 Million CNY | -7.95% |
| 2022 Q3 | -763.68 Million CNY | -2.83% |
| 2022 Q2 | -742.63 Million CNY | -3.72% |
| 2021 Q3 | -611.52 Million CNY | 10.54% |
| 2021 Q4 | -642.18 Million CNY | -5.01% |
| 2021 Q2 | -683.58 Million CNY | 6.88% |
| 2021 Q1 | -734.11 Million CNY | -27.92% |
| 2021 FY | -642.18 Million CNY | -11.9% |
| 2020 Q2 | -776.99 Million CNY | 3.17% |
| 2020 Q1 | -802.44 Million CNY | -6.88% |
| 2020 FY | -573.87 Million CNY | 23.56% |
| 2020 Q3 | -622.94 Million CNY | 19.83% |
| 2020 Q4 | -573.87 Million CNY | 7.88% |
| 2019 FY | -750.77 Million CNY | -63.2% |
| 2019 Q4 | -750.77 Million CNY | -19.96% |
| 2019 Q3 | -625.86 Million CNY | 7.12% |
| 2019 Q2 | -673.86 Million CNY | 7.74% |
| 2019 Q1 | -730.41 Million CNY | -58.77% |
| 2018 Q3 | -428.84 Million CNY | -16.17% |
| 2018 Q2 | -369.13 Million CNY | -36.67% |
| 2018 Q1 | -270.08 Million CNY | -45.35% |
| 2018 FY | -460.04 Million CNY | -147.58% |
| 2018 Q4 | -460.04 Million CNY | -7.28% |
| 2017 Q2 | -143.2 Million CNY | 35.71% |
| 2017 Q4 | -185.81 Million CNY | -5.45% |
| 2017 FY | -185.81 Million CNY | 21.09% |
| 2017 Q3 | -176.2 Million CNY | -23.05% |
| 2017 Q1 | -222.76 Million CNY | 5.4% |
| 2016 FY | -235.47 Million CNY | 13.37% |
| 2016 Q2 | -235.23 Million CNY | 20.85% |
| 2016 Q1 | -297.19 Million CNY | -9.34% |
| 2016 Q4 | -235.47 Million CNY | -4.34% |
| 2016 Q3 | -225.67 Million CNY | 4.07% |
| 2015 Q3 | -246.07 Million CNY | 26.53% |
| 2015 Q2 | -334.9 Million CNY | -7.9% |
| 2015 FY | -271.8 Million CNY | 1.33% |
| 2015 Q1 | -310.36 Million CNY | -12.67% |
| 2015 Q4 | -271.8 Million CNY | -10.46% |
| 2014 Q2 | -265.4 Million CNY | 14.89% |
| 2014 Q1 | -311.85 Million CNY | -201.78% |
| 2014 Q4 | -275.47 Million CNY | -8.22% |
| 2014 FY | -275.47 Million CNY | -166.58% |
| 2014 Q3 | -254.54 Million CNY | 4.09% |
| 2013 Q4 | -103.33 Million CNY | 0.0% |
| 2013 Q1 | 64.05 Million CNY | 200.0% |
| 2013 Q2 | -85.79 Million CNY | -233.94% |
| 2013 FY | -103.33 Million CNY | -61.32% |
| 2013 Q3 | - CNY | 100.0% |
| 2012 Q4 | -64.05 Million CNY | 0.0% |
| 2012 FY | -64.05 Million CNY | -100.17% |
| 2011 FY | -32 Million CNY | -83.62% |
| 2010 FY | -17.42 Million CNY | 59.93% |
| 2009 FY | -43.48 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 935.92 Million CNY | 218.485% |
| Zhejiang Zhenyuan Share Co., Ltd. | -320.75 Million CNY | -245.722% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 580.71 Million CNY | 290.96% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 520.61 Million CNY | 313.004% |
| Yifan Pharmaceutical Co., Ltd. | 1.29 Billion CNY | 185.512% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | -129.14 Million CNY | -758.699% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.88 Billion CNY | 138.498% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -562.43 Million CNY | -97.166% |
| Boai NKY Medical Holdings Ltd. | -230.36 Million CNY | -381.378% |